Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 PolarityTEKiromic BioPharmaWindtree TherapeuticsBrickell BiotechGenetic Technologies
SymbolNASDAQ:PTENASDAQ:KRBPNASDAQ:WINTNASDAQ:BBINASDAQ:GENE
Price Information
Current Price$0.91$8.50$2.14$0.84$3.85
52 Week RangeBuyN/ABuyBuyN/A
MarketRank™
Overall Score1.41.02.31.50.4
Analysis Score3.30.03.53.50.0
Community Score2.75.05.01.31.9
Dividend Score0.00.00.00.00.0
Ownership Score0.00.01.71.70.0
Earnings & Valuation Score1.30.01.31.30.0
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyN/A
Consensus Price Target$4.00N/A$12.25$5.50N/A
% Upside from Price Target341.70% upsideN/A472.43% upside551.50% upsideN/A
Trade Information
Market Cap$104.20 million$63.80 million$54.62 million$55.02 million$56.96 million
Beta1.29N/A0.250.342.65
Average Volume7,952,37021,664332,6143,485,2821,915,424
Sales & Book Value
Annual Revenue$5.65 millionN/A$200,000.00$7.92 million$10,000.00
Price / Sales19.39N/A280.957.135,785.78
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.42 per shareN/A$5.48 per share$0.97 per share$0.65 per share
Price / Book0.64N/A0.390.875.92
Profitability
Net Income$-92,490,000.00N/A$-27,480,000.00$-23,880,000.00$-4,090,000.00
EPS($3.70)N/A($2.52)($5.11)N/A
Trailing P/E RatioN/A0.00N/AN/A0.00
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-674.12%N/AN/A-990.67%N/A
Return on Equity (ROE)-169.92%N/A-43.46%-187.45%N/A
Return on Assets (ROA)-105.62%N/A-26.55%-114.85%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.08%N/A0.18%N/A0.02%
Current Ratio3.22%N/A2.75%3.50%10.88%
Quick Ratio3.11%N/A2.75%3.50%10.81%
Ownership Information
Institutional Ownership Percentage16.51%N/A1.59%5.93%1.39%
Insider Ownership Percentage5.50%N/A14.91%10.30%N/A
Miscellaneous
Employees153193113N/A
Shares Outstanding120.97 million7.33 million26.26 million66.93 million15.03 million
Next Earnings Date5/10/2021 (Estimated)6/30/2021 (Estimated)5/13/2021 (Estimated)5/12/2021 (Estimated)N/A
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable
SourceHeadline
If You’re Not Bullish on Applied Genetic Technologies Corporation (NASDAQ:AGTC) Now, You’ll Kick Yourself LaterIf You’re Not Bullish on Applied Genetic Technologies Corporation (NASDAQ:AGTC) Now, You’ll Kick Yourself Later
stocksregister.com - April 20 at 1:26 PM
NGS Sample Preparation Market Size, Growth, Trends, Demand, Applications, Types, Technology, Industry Analysis and Forecasts Research Report 2027NGS Sample Preparation Market Size, Growth, Trends, Demand, Applications, Types, Technology, Industry Analysis and Forecasts Research Report 2027
sbwire.com - April 13 at 4:16 PM
Genetic Technologies Limited (GENE) investors to reap big returns againGenetic Technologies Limited (GENE) investors to reap big returns again
marketingsentinel.com - April 13 at 11:16 AM
Will current price volatility hamper Applied Genetic Technologies Corporation (AGTC) future potential?Will current price volatility hamper Applied Genetic Technologies Corporation (AGTC) future potential?
marketingsentinel.com - April 12 at 12:35 PM
What Is Going On With Applied Genetic Technologies Corporation (NASDAQ:AGTC)?What Is Going On With Applied Genetic Technologies Corporation (NASDAQ:AGTC)?
stocksregister.com - April 12 at 12:35 PM
Genetic Technologies Limited [GENE] moved up 6.53: Why It’s ImportantGenetic Technologies Limited [GENE] moved up 6.53: Why It’s Important
dbtnews.com - April 12 at 12:35 PM
Company News for Apr 12, 2021Company News for Apr 12, 2021
finance.yahoo.com - April 12 at 12:35 PM
Genetic Technologies Limited (NASDAQ:GENE) Stock Sentiment Check: What Does Wall Street Say?Genetic Technologies Limited (NASDAQ:GENE) Stock Sentiment Check: What Does Wall Street Say?
stocksregister.com - April 12 at 7:35 AM
Genetic Link Discovered Between Face and Brain ShapeGenetic Link Discovered Between Face and Brain Shape
scitechdaily.com - April 11 at 2:38 PM
Advanced computer model could lead to improvements in bionic eye technologyAdvanced computer model could lead to improvements in 'bionic eye' technology
news-medical.net - April 11 at 2:38 PM
Genetic Engineering 2.0: An On-Off Switch for Gene EditingGenetic Engineering 2.0: An On-Off Switch for Gene Editing
scitechdaily.com - April 11 at 2:38 PM
Genetic Technologies Provides Update on COVID-19 Risk Test LaunchGenetic Technologies Provides Update on COVID-19 Risk Test Launch
finance.yahoo.com - April 9 at 11:58 AM
Advanced Analytics Advancing Development of Genetic VaccinesAdvanced Analytics Advancing Development of Genetic Vaccines
contractpharma.com - March 29 at 3:40 PM
Genetic Technologies Limited (NASDAQ:GENE) Has Recovered 65.39% So Far, But Another 145.82% Gain Cannot Be Ruled OutGenetic Technologies Limited (NASDAQ:GENE) Has Recovered 65.39% So Far, But Another 145.82% Gain Cannot Be Ruled Out
marketingsentinel.com - March 27 at 2:38 PM
Is Applied Genetic Technologies Corporation (NASDAQ:AGTC) Still A Good Investment?Is Applied Genetic Technologies Corporation (NASDAQ:AGTC) Still A Good Investment?
stocksregister.com - March 26 at 10:06 AM
BIO Letter to DEFRA Consultation on the Regulation of Genetic TechnologiesBIO Letter to DEFRA Consultation on the Regulation of Genetic Technologies
bio.org - March 18 at 7:35 AM
Applied Genetic Technologies Corp. (NASDAQ: AGTC) Featured in Virtual Coverage of the 33rd Annual ROTH ConferenceApplied Genetic Technologies Corp. (NASDAQ: AGTC) Featured in Virtual Coverage of the 33rd Annual ROTH Conference
marketwatch.com - March 17 at 9:31 AM
Animal Genetics Market High Demand, Recent Trends, Future Growth, Business Scenario, Product, Technology, Share and Forecasts 2020 - 2027Animal Genetics Market High Demand, Recent Trends, Future Growth, Business Scenario, Product, Technology, Share and Forecasts 2020 - 2027
marketwatch.com - March 15 at 10:26 PM
Genetic Technologies pairs up with Infinity Biologix for COVID-19 risk testGenetic Technologies pairs up with Infinity Biologix for COVID-19 risk test
bioworld.com - March 5 at 6:59 PM
Fact Check-The COVID-19 vaccine does not change recipients’ genetic makeupFact Check-The COVID-19 vaccine does not change recipients’ genetic makeup
reuters.com - March 5 at 8:58 AM
Could science of genetic genealogy help solve Jonathan Foundling case?Could science of genetic genealogy help solve Jonathan Foundling case?
onlineathens.com - March 4 at 10:23 AM
Global Genetic Toxicology Testing Market Size, Share, Value, and Competitive Landscape 2021Global Genetic Toxicology Testing Market Size, Share, Value, and Competitive Landscape 2021
marketwatch.com - March 3 at 7:04 PM
Johnson & Johnson’s vaccine uses different technology than Moderna, Pfizer’sJohnson & Johnson’s vaccine uses different technology than Moderna, Pfizer’s
thedenverchannel.com - March 3 at 9:02 AM
Biden’s Top Science Nominee Advocated ‘Preimplantation Genetic Testing’ to Decide Which Human Embryo to KeepBiden’s Top Science Nominee Advocated ‘Preimplantation Genetic Testing’ to Decide Which Human Embryo to Keep
cnsnews.com - March 3 at 9:02 AM
How Genetic Testing Can Impact Health and WellnessHow Genetic Testing Can Impact Health and Wellness
news.yahoo.com - March 3 at 9:02 AM
DateCompanyBrokerageAction
11/10/2020PolarityTECantor FitzgeraldReiterated Rating
9/8/2020PolarityTEOppenheimerReiterated Rating
7/24/2020PolarityTENorthland SecuritiesReiterated Rating
5/12/2020PolarityTEHC WainwrightReiterated Rating
11/13/2019PolarityTEPiper Jaffray CompaniesLower Price Target
5/13/2019PolarityTENational SecuritiesLower Price Target
6/26/2020Windtree TherapeuticsLADENBURG THALM/SH SHInitiated Coverage
8/28/2020Brickell BiotechLake Street CapitalInitiated Coverage
(Data available from 4/21/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.